Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemiaEric I. Zimmerman, Sharyn D. Baker, Clinton F. Stewart et al.|Blood|2013Cited by 184
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance studyKrzysztof Mrózek, Ann‐Kathrin Eisfeld, Jessica Kohlschmidt et al.|Leukemia|2023Cited by 76
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemiaA-K Eisfeld, Clara D. Bloomfield, Jessica Kohlschmidt et al.|Leukemia|2016Cited by 67
Abstract C170: GDC-0941 inhibits cytarabine-induced PI3K/AKT signaling and promotes synergistic activity in acute myeloid leukemia.Christina D. Drenberg, Sharyn D. Baker, Brian Fermanski et al.|Molecular Cancer Therapeutics|2013Cited by 0